Chemical Structure and Pharmacodynamics
From a chemical structure perspective, articaine is a thiophenecarboxylic acid methyl ester. An important distinguishing feature of its molecule is the presence of a specific thiophene ring (unlike the benzene, imidazole, or pyridine rings found in other compounds). In medical practice, the drug is traditionally used in the hydrochloride form.
The drug's pharmacodynamic profile is characterized by an extremely rapid onset of analgesic effect. The average duration of anesthetic action ranges from 1 to 3 hours. The drug is successfully used for several types of local anesthesia:
- Infiltration anesthesia;
- Nerve block anesthesia;
- Spinal anesthesia.
Note: Articaine is not intended for epidural or topical (surface) anesthesia.
Clinical Features and Advantages
The drug possesses a number of unique properties that make it indispensable in certain fields of medicine.
Use in Dentistry A huge advantage of articaine is its ability to maintain high clinical efficacy even in the presence of tissue inflammation. As is known, during inflammatory processes, the local pH of the medium significantly decreases (tissue acidosis). Under such conditions, most other local anesthetics lose their activity and work much less effectively, whereas articaine provides reliable anesthesia.
Use in Obstetrics In obstetrics, a 2% articaine solution is officially considered the drug of choice. The main reason for this status is the extremely low ability of the molecule to cross the placental barrier. The degree of transplacental transfer for articaine is significantly lower than that of most other local anesthetics. As a direct consequence of this property, there is a complete absence of adverse toxic effects on the developing fetus.
Adverse Reactions and Side Effects
Despite its high safety profile, the use of the drug may be accompanied by several side effects. Most frequently, these affect the central nervous system (CNS) and the immune system.
- CNS effects: patients may report headache, nausea, and vomiting. Visual disturbances such as blurred vision or diplopia (double vision) may occur. In some cases, muscle twitching is noted. In severe reactions, although very rare, impairment or even complete loss of consciousness can occur.
- Allergic reactions: local manifestations such as edema and hyperemia directly at the injection site are possible. In more serious clinical situations, there is a risk of developing angioedema.
Contraindications and Drug Combinations
The administration of articaine requires strict consideration of contraindications. These include:
- Confirmed hypersensitivity to articaine itself or to preservatives (especially sulfites) frequently included in the finished pharmaceutical formulation;
- Significant cardiac rhythm disturbances;
- Diagnosed angle-closure glaucoma.
Crucially important: Intravenous administration of articaine is absolutely contraindicated due to the high risk of life-threatening systemic reactions.
To optimize its pharmacological profile, articaine is frequently combined with vasoconstrictors. The addition of epinephrine (adrenaline) to the solution performs two critical functions: first, it substantially reduces the resorptive toxicity of the drug (as vasoconstriction slows down the absorption of the anesthetic into the systemic circulation), and second, it significantly prolongs the duration of local anesthesia.